Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Zalevsky Jonathan Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 9,703 shares @ $0.78, valued at $7.6k
05/17/2023 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 9,791 shares @ $0.72, valued at $7k
11/18/2022 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 13,460 shares @ $3.57, valued at $48.1k
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 10,912 shares @ $10.95, valued at $119.5k
12/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2021 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,150 shares @ $0
Sold 20,869 shares @ $13.16, valued at $274.6k
10/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 24,141 shares @ $22.37, valued at $540k
12/22/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,000 shares @ $0
Granted 71,500 options @ $18.75, valued at $1.3M
11/25/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 16,380 shares @ $16.4, valued at $268.6k
11/18/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 29,618 shares @ $16.93, valued at $501.4k
08/19/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 26,200 shares @ $19.67, valued at $515.4k
05/20/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 4,558 shares @ $22.51, valued at $102.6k
02/20/2020 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 4,774 shares @ $22.35, valued at $106.7k
12/16/2019 4 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,150 shares @ $0
Granted 71,550 options @ $21.79, valued at $1.6M
Granted 20,100 options @ $21.79, valued at $438k
11/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2019 3 Zalevsky Jonathan (Chief R&D Officer) has filed a Form 3 on NEKTAR THERAPEUTICS

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy